SCHEMBL2833217

SCHEMBL2833217

O=C(Cc1cccc(OC(F)(F)F)c1)N1CCC(N2CCCC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
OPRD1 P41143 1/20 0.49
OPRK1 P41145 1/20 0.49
POLB P06746 1/20 0.46
L3MBTL3 Q96JM7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ACHE P22303 1/20 0.46
RIPK1 Q13546 1/20 0.46
ACACB O00763 1/20 0.45
ACACA Q13085 1/20 0.45
EPHX1 P07099 1/20 0.45
SIGMAR1 Q99720 1/20 0.44
HSD11B1 P28845 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4378673 0.91 KDM4E (0.62) MEN1KMT2AKDM4EALDH1A1OPRD1
SCHEMBL4378669 0.90 KDM4E (0.61) MEN1KMT2AKDM4EALDH1A1OPRD1
SCHEMBL2836399 0.86 HRH3 (0.58) KDM4EALDH1A1L3MBTL3L3MBTL1ACHE
SCHEMBL3765916 0.86 KDM4E (0.53) MEN1KMT2AKDM4EALDH1A1OPRD1
SCHEMBL14218030 0.78 HSD11B1 (0.60) MEN1KMT2AKDM4EALDH1A1OPRD1
SCHEMBL13090033 0.77 OPRD1 (0.49) MEN1KMT2AOPRD1OPRK1RIPK1
SCHEMBL4380547 0.77 ALDH1A1 (0.64) KMT2AKDM4EALDH1A1HRH3
SCHEMBL2828800 0.77 ACHE (0.67) CYP2D6CYP2C19NPSR1KDM4EALDH1A1
SCHEMBL4976765 0.76 ENPP2 (0.42) KDM4EALDH1A1RIPK1SIGMAR1
SCHEMBL4375759 0.76 ALDH1A1 (0.63) KMT2AKDM4EALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed